Abril-Julio 2002 11
ISSN 1317-987X
 
Buscar




Artículos
 



Anatomía Patológica
Aplicación del anticuerpo CD34 en el diagnóstico diferencial de los tumores fusocelulares

Bibliografía

  1. Guevara ME, Mota D, Grases PJ, García Tamayo J. Tumores fusocelulares de difícil diagnóstico: estudio histológico y ultraestructural. Morfol Norm y Patol. Secc B (Esp) 1980, 4:533 - 548.
  2. García Tamayo J, Fraiz Grijalba T, Oviedo de Ayala N, Pinto JA. Tumores de músculo liso estudio clínico, histológico y ultraestructural. Patología (Mex) 1980, 18: 221 - 238.
  3. García Tamayo J. Aspectos ultraestructurales de la patología tumoral. Invest Clin 1982, 3: 123-215.
  4. Battifora H. Recent Progress in the Immunohistochemistry of Solid Tumors. Sem Diag Pathol 1984, 1: 252 - 271.
  5. García Tamayo J. Ultraestructura e inmunohistoquímica como ayuda diagnóstica en Anatomía Patológica. Rev Ven de Oncología 1991, 3: 1- 7.
  6. Ramani P, Bradley NJ, Fletcher CDM QBEND/10 a new monoclonal antibody to endothelium: assesment of its diagnostic utility in parafin sections. Histopathology 1990, 17: 237-242.
  7. van de Rijn M, Rouse RV. CD34: a review. Appl Immunohistochem 1994, 2: 71-80.
  8. Schilgemann RO, Rietveld FJ, de Wall RM y col. Leucocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelila abluminal microprocesses in the tumor stroma. Lab Invest 1990, 62: 690-696.
  9. Suster S, Wong TY. On the discriminatory value of anti - HPCA-1 ( CD34 ) in the differential diagnosis of benign and malignant cutaneous vascular proliferations. Am J Dermatopathol 1994, 16: 355-363.
  10. Weiss SW, Nickoloff BJ. CD34 is expressed by a distinct population of peripheral nerve, nerve sheath tumors and related lesions. Am J Surg Pathol 1993, 17: 1039-1045.
  11. van de Rijn M, Lombard CM, Rouse RV. Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum and lung. Am J Surg Pathol 1994, 18: 814-820.
  12. Hiha S, Tabata N, Ishii H y col. Deramtofibrosarcoma protuberans is an unique fibrohistiocytic tumor expressing CD34. Brit J Cancer 1992, 127: 79-84.
  13. Arber DA, Kandalaft PL, Metha P, Battifora H. Vimentin negative epithelioid sarcoma. The value of an immunohistochemical panel that includes CD34. Am J Surg Pathol 1993, 17: 302-307.
  14. Michael AJ, Bacchi CE, Zarbo RJ, Ma CK, Gown DM. CD34 expression in stromal tumors of the gastrointestinal tract. Appl Immunohistochem 1994, 2: 89-93.
  15. Suster S, Fisher C. Immunoreactivity for the hematopoyetic progenitor cell antigen (CD34) in lipomatous tumors. Am J Surg Pathol 1997, 21: 195-200.
  16. Nickoloff BJ. The human progenitor cell antigen (CD34) is located on endothelial cells, dermal dendritic cells, and perifolicular cells in formalin fixed normal skin and on proliferating endothelial cells and stromal spindle shaped cells in Kaposi´s sarcoma. Arch Dermatol 1991, 127: 523-529.
  17. Klemperer P, Rabin CB. Primary neoplasms of the pleura: a report of five cases. Arch Pathol 1931, 11: 385-412.
  18. Goodland JR, Fletcher CDM. Solitary fibrous tumor arising at unusual sites. Histopathol 1991, 19: 515-522.
  19. Fukanagua M, Nagamura H, Ushigome S, Endo Y, Ishikawe E. Malignant solitary fibrous tumor of the peritoneum. Histopathology 1996, 28: 463-466.
  20. Vallat-Decouvelaere SMD, Fletcher CDM. Solitary fibrous tumors in extrathoraxic locations. Am J Surg Pathol 1998, 22: 1501-1511.
  21. Nielsen GP, Conell JY, Dickersen GR, Rosemberg AE. Solitary Fibrous Tumor of soft tissue: a report of 15 cases, including 5 malignant examples with light microscopy, immunohistochemical and ultrastructural data. Mod Pathol 1997, 10: 1028-1037.
  22. Hasegawa T, Matsuno Y, Shimada T, Hasegawa MT, Sano T, Hiroshi S Extratoraxic solitary fibrous tumors: their histological variability and potentially aggresive behavior. Human Pathol 1999, 30: 1464-1473.
  23. Kuroda HM, Nakamura N, Nakatani Y y col. Solitary fibrous tumor: significance of p53 and CD34 immunoreactivity in its immunotransformation. Histopathology 1998, 32: 423-432.
  24. Nafussi AA, Wong NACS. Intrabdominal spindle cell lesions: a review and practical aids to diagnosis. Histopathol 2001, 38: 387-402.
  25. Suster S. Gastrointestinal stromal tumors. Sem Diagnost Pathol 1996, 435: 143-150.
  26. 26-Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Huma Pathol 1999, 30: 1213-1220.
  27. Monihan JM, Carr NJ, Sobin LH. CD34 immunoexpression in stromal tumors of teh gastrointestinal tract and in mesenterio fibromatosis. Histopathology 1994, 25: 469-473.
  28. Emory TS, Sobin LH, Lukes L y col. Prognosis of gastrointestinal smooth-muscle ( stromal ) tumors. Am J Surg Pathol 1999, 23: 82-87.
  29. Franquemont DN, Frerson HF. Proliferating cell nuclear antigen immunoreactivity and prognosis of gastrointestinal stromal tumors. Mod Pathol 1995, 8: 473-477.
  30. Rizeq MN, van de Rijn M, Hendrickson MR, Rouse RV. A comparative immunohistochemical study of uterine smooth muscle neoplasms with emphasis on the epithelioid variant. Human Pathol 1994, 25: 671-677.
  31. Chu PG, Arber DA, Weiss LM, Chang KL. Utility of CD10 in distinguishing between Endometrial Stromal Sarcoma and Uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathl 2001, 14: 465-471.
  32. Santa Cruz D, Kyriakos M. Aneurismal ( "angiomatoid") fibrous histiocytoma of the skin. Cancer 1981, 47: 2053-2061.
  33. Leong AS, Milios J. Atypical fibroxantoma of the skin: a clinicopathological and immunohistochemical study and a discussion of its histogenesis. Histopathology 1987, 11: 463-475
  34. Calonje E, Wadden C, Wilson-Jones E, Fletcher CDM. Spindle-cell non-pleomorphic atypical fibroxantoma: analysis of a series and delineation of a distinct variant. Histopathology 1993, 22: 247 - 254.
  35. Taylor HB, Helwig EB. Dermatofibrosarcoma protuberans: a study of 115 cases. Cancer 1962, 15: 717-725.
  36. Dupree WB, Langloss JM, Weeiss SW. Pigmented dermatofibrosarcoma protuberans (Bednar tumor): a pathologic, ultraestructural and immunohistochemical study. Am J Surg Pathol 1985, 9: 630-639.
  37. Onoda N, Tsutsumi Y, Kakudo K y col. Pigmented Dermatofibrosarcoma protuberans (Bendar tumor): an autopsy case with sistemic metastasis. Acta Path Jap 1990, 40: 335-340.
  38. Albenoza P, Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Surg Pathol 1993, 17: 429-434.
  39. Goldblum JR, Reith JD, Weiss SW. Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up. Am J Surg Pathol 2000, 24: 1125-1130.
  40. Mentzel T, Behan A Katemkamp D, Deitos AP, Fletcher CDM. Fibrosarcomatous (high grade) dermatofibrosarcoma protuberans: clinicopathologc and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol 1998, 22: 576-587.
  41. Fujiwara ST, Akashi-Tanaka S, Fukutomi T. A case of dermatofibrosarcoma protuberans in the skin over the breast. Breast cancer 1997, 25: 53-56.
  42. Karcnick TJ, Miller JA, Fromowitz F, Abujudeh H, Hertz MB. Dermatofibrosarcoma protuberans of the breast. A rare malignant tumor sumulating benign disease. Breast J. 1999, %: 262-263.
  43. Wesche WA, Fletcher CDM, Dias P, Houghton PJ, Parham DM. Immunohistochemistry of myoD1 in adult pleomorphic soft tissues sarcomas. A, J Surg Pathol 1996, 19: 261-269.
  44. Schirch W, Begm LR, Seemayer TA, Legace R y col. Pleomorphic Soft Tissue Myogenic Sarcomas of Adulthood. A reappraisasl in the Mid-199s. Am J Surg Pathol 1996, 20: 131-147.
  45. Furlong MA, Mentzel T, Farburg-Smith JC. Pleomorphic Radbdomyosarcomas in adults. A clinicopathologic satudy of 38 cases with emphasis on morphologic variants and recent skeletal-muscle specific markers. Mod Pathol 2001, 14: 595-603.
  46. Kauffman SL, Stout AP. Histiocytic tumors ( fibrous xantoma and histiocytoma ) in children. Cancer 1961, 14: 469-482.
  47. O´Brien JE, Stout AP. Malignant Fibroxantoma. Cancer, 1964, 17 : 1445-1455.
  48. Enzinger FM. Malignant fibrous histiocytoma. Twenty years after Stout. Am J Surg Pathol (Suppl) 1986:, 10: 43-53.
  49. Alguacil-García A, Unni KK, Goellner JR. Malignant fibrous histiocytoma. An ultrastructural study of six cases. Am J Clin Pathol 1978, 69:121-129.
  50. Lawson CW, Fisher C, Gatter KC. An immunohistochemical study of differentiation in malignant fibrous histiocytoma. Histopathology 1987, 11: 375-383.
  51. Michelena A, Delgado GE, García Tamayo J. Fibrohistiocitoma Maligno de hueso. Presentación de cinco casos. Patología (Mex) 1980, 18: 281 - 295.
  52. Fletcher CDM. Pleomorphic Malignant Fibrous Histiocytoma: fact or fiction? 1992, Am J Pathol 16: 213-228.
  53. MaggioP, Szumigala J, Brooks JJ. CD34 positive spindle cell lipoma: are some cases incipient solitary fibrous tumors? Mol Pathol 1996, 9: 10A
  54. Downes RA, Goldblum JR, Montgomery EA, Fisher C. Pleomorphic Liposarcoma: a clinicopathologic analysis of 19 cases. Mod Pathol 2001, 14. 179-184.
  55. Mieettinen M, Enzinger FM. Epithelioid variant of Pleomorphic Liposarcoma: a study of 12 cases of a distinctive variant oh high-grade liposarcoma. Mod Pathol 1999, 12:722-228.
  56. Stout AP, Murray MR. Hemangiopericytoma. A vascular tumor featuring Zimmerman´s pericytes. Ann Surg 1942, 116: 26-51.
  57. Battifora H. Hemangiopericytoma. Ultrastructural study of five cases. Cancer 1973, 31: 1418-1432.
  58. Schurch W, Skalli O, Legace R y col. Intermediate filament proteins and actin isoforms as markers for soft-tissue tumor differentiation and origin. III Hemangiopericytomas and glomus tumors. Am J Pathol 1990, 136: 771-786.
  59. Nemes Z. Differentiaton markers in hemangiopericytoma. Cancer 1992, 69: 133-140.
  60. Middleton LP, Duray PH, Merino MJ. The histological spectrum of hemangiopericytoma: application of immunohistochemical analysis including proliferative markers to facilitate diagnosis and predict prognosis. Hum Pathol 1998, 29: 636-640.
  61. Kempson RL, Fletcher CDM, Evans HL, Hendrickson MR, Sibley RK. Tumors of the Soft Tisssues. Atlas of Tumor Pathology 3rd Series. Perivascular Tumors. 2001, Fasc 30: 371-385.
  62. Mac Master MJ, Soule EH, Jvims JC. Hemangiopericytoma: a clinicopathologic study and long term follow up of 60 patients. Cancer 1975, 36: 2232-2244.
  63. Kauffman SL, Stout AP. Hemangiopericytoma in children. Cancer 1960, 13: 695-710.
  64. Bailey P, Cushing H, Eisenhardt L. Angioblastic meningioma. Arch Pathol 1928, 6: 453-490.
  65. Kawashima M, Suzuki SO, Yamashima T, Fukui M,Iwaki T. Prostaglandin D synthetase (betha-trace) in meningeal Hemangiopericytoma. Mod Pathol 2001, 14: 197-201.
  66. DeYoung BR, Wick MR, Figzgibbon JF, Sirgi KE, Swansosn PE. CD31: An immunospecific marker for endothelial differentiation in humans neoplasms. Appl Immunohistochem 1993, 1: 97-100.
  67. Kempson RL, Fletcher CDM, Evans HL, Hendrickson MR, Sibley RK. Tumors of the Soft Tisssues. Atlas of Tumor Pathology 3rd Series. Vascular Tumors. 2001, Fasc 30: 307-370.
  68. Rabkin CS, Janz S, Lash H y col. Monoclonal origin of multicentric Kaposi´s sarcoma lesions. New England J Med 1997, 336: 988-993.
  69. Trujillo B, García Tamayo J. Sarcoma de Kaposi clásico y contemporáneo. Estudio clínico, histológico y ultraestructural. Avances en Patología. Luna MA, Blasco Olaetxea E, García Tamayo J, Editores. 2001, Vol 3: 79-92.
  70. Dictor M, Rambech E, Way D, Witte M, Bendsoe N. Human Herpes virus 8 (Kaposi´s sarcoma-associated herpesvirus) DNA in Kaposi´s sarcoma lesions. AIDS Kaposi´s sarcoma cell lines, endothelial Kaposi´s sarcoma simulators and the skin of immunosupressed patients. Am J Patol 1996, 148: 2009-2016.
  71. O´Leary JJ, Kennedy MM, McGee JO. Kaposi´s sarcoma associated herpes virus ( KSHV / HHV b ): epidemiology, molecular biology and tissue distribution. Molec Pathol 1997,5: 4-8.
  72. Rosai J, Sumner HK, Kostianovsky M, Pérez Mesa C. Angiosarcoma of the skin. A clinicopathologic anbd finestructural study. Huma Pathol 1976, 1: 64-81.
  73. Mark RJ, Poen JC, Tran LM, Fu YS, Julliard GF. Angiosarcoma. A report of 67 patients and a review of the literature. Cancer 1996, 77: 2400-2406.
  74. Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cáncer 1982, 14: 970-981.
  75. García Tamayo J, Ruíz ME. Hemangioma histiocitoide y hemangioendotelioma epitelioide. Estudio histológico, inmunohistológico y ultraestructural. Patología (Esp) 1989, 22:170 -180.
Introducción
Material y métodos
Resultados
Discusión
Bibliografía

NOTA: Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.





Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO,
caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit